Clinical Trial Update: Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating continuous soluble ferric pyrophosphate citrate iron delivery via dialysate in hemodialysis patients; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Triferic (ferric pyrophosphate)

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: Renal Failure Chronic Requiring Hemodialysis | Phase 3 | Status: COMPLETED | Results posted: 2015-04-28